Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer

Authors:	Fatih Selcukbiricik MD Elif Ozdogan MD Tuncay Dagel MD Serhan Tanju MD Suat Erus MD Lale A. Ertuglu MD Murat Kapdağlı MD Deniz Tural MD Ahmet Bilici MD Sukru Dilege MD Nil M. Mandel MD Mehmet Kanbay MD

Affiliation:	1. Department of Medical Oncology, Faculty of Medicine, Koc University, Istanbul, Turkey;2. Koc University School of Medicine, Istanbul, Turkey;3. Department of Nephrology, Koc University Hospital, Istanbul, Turkey;4. Department of Thoracic Surgery, Faculty of Medicine, Koc University, Istanbul, Turkey;5. Department of Thoracic Surgery, Koc University Hospital, Istanbul, Turkey;6. Department of Thoracic Surgery, VKV American Hospital, Istanbul, Turkey;7. Department of Medical Oncology, Bakırköy Sadi Konuk Education and Training Hospital, Istanbul, Turkey;8. Department of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul, Turkey;9. Department of Medical Oncology, Faculty of Medicine, Koc University, Istanbul, Turkey Department of Medical Oncology, VKV American Hospital, Istanbul, Turkey;10. Department of Nephrology, Faculty of Medicine, Koc University, Istanbul, Turkey

Abstract:

Keywords:	erlotinib lung cancer uric acid